淋巴结转移与胸腺上皮及神经内分泌癌的外科治疗
16例(30.2%)发现淋巴结转移,与更差总生存相关(HR 3.03,95%CI 1.03–8.87,p=0.044)。Masaoka-Koga分期4期及器官转移亦为不良预后因素,建议将淋巴结清扫作为胸腺恶性肿瘤手术常规部分。
要点
- 胸腺癌可切除患者淋巴结转移率达30.2%,阳性淋巴结与更差总生存相关。
- Masaoka-Koga分期4期和器官转移是独立不良预后因素。
- 淋巴结清扫可提供最佳分期,应作为胸腺恶性肿瘤手术常规部分。
核心结论
- 可切除胸腺神经内分泌肿瘤或癌的淋巴结转移率高,阳性淋巴结与更差结局相关。
- 淋巴结清扫提供最佳分期,应作为胸腺恶性肿瘤手术的常规部分。
研究设计与样本
- 回顾性单中心分析1999–2016年接受手术切除的53例胸腺上皮或神经内分泌癌患者。
主要发现
- 16例(30.2%)发现淋巴结转移,其中pN1 11例、pN2 5例。
- 淋巴结转移与更差总生存相关(HR 3.03,95%CI 1.03–8.87,p=0.044)。
- Masaoka-Koga分期4期较1–3期预后更差(HR 7.01,95%CI 2.52–19.50,p=0.0002)。
- 18例在胸腺切除时存在器官转移,与更差结局相关(HR 5.8,95%CI 2.04–16.79,p=0.001)。
临床怎么用
- 对胸腺恶性肿瘤患者,手术中应常规行淋巴结清扫以获取最佳分期。
- 淋巴结转移阳性提示预后不良,需考虑辅助治疗和多学科管理。
局限性
- 回顾性单中心分析,样本量53例,可能存在选择偏倚。
- 需要前瞻性研究探索系统淋巴结清扫和辅助治疗能否改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thymic epithelial and neuroendocrine carcinomas are rare malignancies, and only a few prognosticators are defined. Surgery is the mainstay of treatment, and complete resection contributes to superior outcome. Systematic lymph node dissection is not routinely performed in thymic malignancies. The aim of this study was to assess the impact of histologically confirmed lymph node metastases on the outcome after thymectomy. METHODS: We identified 53 patients with thymic epithelial or neuroendocrine carcinomas who underwent surgical resection at our center between 1999 and 2016. The clinical follow-up was retrospectively collected, and the impact of clinicopathologic factors on overall survival was analyzed. RESULTS: Ninety-one percent of the patients were treated taking a multimodal approach. Median overall survival was 11.3 years. Lymph node metastases were identified in 16 patients (30.2%; 11 pN1 and 5 pN2). Lymph node metastasis was associated with inferior overall survival (hazard ratio [HR] 3.03, 95% confidence interval [CI]: 1.03 to 8.87, p = 0.044). Masaoka-Koga stage (4 versus 1 to 3) was another significant prognosticator (HR 7.01, 95% CI: 2.52 to 19.50, p = 0.0002). Organ metastases were present in 18 patients at the time of thymectomy and were associated with inferior outcome (HR 5.8, 95% CI: 2.04 to 16.79, p = 0.001). CONCLUSIONS: This retrospective, single-center analysis demonstrates a high rate of lymph node metastasis in resectable thymic neuroendocrine tumors or carcinomas. Positive lymph nodes are associated with an inferior outcome. Prospective studies are warranted to explore whether this outcome can be improved by systematic lymphadenectomy and adjuvant therapies. Nevertheless, lymphadenectomy provides optimal staging and should be a routine part of surgery for patients with thymic malignancies.
引用
- Cheufou DH, Valdivia D, Puhlvers S, et al. Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine Carcinoma. Ann Thorac Surg. 2019. PMID: 30721691. doi:10.1016/j.athoracsur.2019.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。